This item is authorised by the following title:
For transitional provisions relating to the repeal of this standard, see subsections 4(2) and (3) of the Therapeutic Goods (Poisons Standard—February 2023) Instrument 2022.
View Explanatory Statement/s
For transitional provisions relating to the repeal of this standard, see subsections 4(2) and (3) of the Therapeutic Goods (Poisons Standard—February 2023) Instrument 2022.